Filter News
Area of Research
- (-) Materials (7)
- (-) National Security (9)
- (-) Neutron Science (5)
- (-) Quantum information Science (2)
- Advanced Manufacturing (1)
- Biological Systems (1)
- Biology and Environment (16)
- Building Technologies (1)
- Clean Energy (18)
- Computer Science (1)
- Energy Sciences (1)
- Fusion and Fission (2)
- Fusion Energy (1)
- Isotopes (2)
- Nuclear Science and Technology (2)
- Supercomputing (28)
News Topics
- (-) Biomedical (4)
- (-) Cybersecurity (11)
- (-) Space Exploration (1)
- (-) Sustainable Energy (7)
- 3-D Printing/Advanced Manufacturing (11)
- Advanced Reactors (3)
- Artificial Intelligence (9)
- Big Data (3)
- Bioenergy (6)
- Biology (1)
- Biotechnology (1)
- Buildings (3)
- Chemical Sciences (17)
- Clean Water (3)
- Climate Change (3)
- Composites (3)
- Computer Science (13)
- Coronavirus (2)
- Critical Materials (4)
- Decarbonization (6)
- Energy Storage (12)
- Environment (12)
- Fossil Energy (1)
- Fusion (5)
- Grid (5)
- High-Performance Computing (4)
- Irradiation (1)
- Isotopes (4)
- Machine Learning (9)
- Materials (44)
- Materials Science (27)
- Microscopy (8)
- Molten Salt (2)
- Nanotechnology (11)
- National Security (14)
- Net Zero (1)
- Neutron Science (45)
- Nuclear Energy (14)
- Partnerships (9)
- Physics (13)
- Polymers (6)
- Quantum Computing (2)
- Quantum Science (7)
- Renewable Energy (1)
- Security (3)
- Transportation (9)
Media Contacts
A technology developed at ORNL and used by the U.S. Naval Information Warfare Systems Command, or NAVWAR, to test the capabilities of commercial security tools has been licensed to cybersecurity firm Penguin Mustache to create its Evasive.ai platform. The company was founded by the technology’s creator, former ORNL scientist Jared M. Smith, and his business partner, entrepreneur Brandon Bruce.
U2opia Technology, a consortium of technology and administrative executives with extensive experience in both industry and defense, has exclusively licensed two technologies from ORNL that offer a new method for advanced cybersecurity monitoring in real time.
Oak Ridge National Laboratory will give college students the chance to practice cybersecurity skills in a real-world setting as a host of the Department of Energy’s fifth collegiate CyberForce Competition on Nov. 16. The event brings together student teams from across the country to compete at 10 of DOE’s national laboratories.
Researchers at the Department of Energy’s Oak Ridge National Laboratory have received five 2019 R&D 100 Awards, increasing the lab’s total to 221 since the award’s inception in 1963.
Three researchers at Oak Ridge National Laboratory will lead or participate in collaborative research projects aimed at harnessing the power of quantum mechanics to advance a range of technologies including computing, fiber optics and network
Quanex Building Products has signed a non-exclusive agreement to license a method to produce insulating material from ORNL. The low-cost material can be used as an additive to increase thermal insulation performance and improve energy efficiency when applied to a variety of building products.
A modern, healthy transportation system is vital to the nation’s economic security and the American standard of living. The U.S. Department of Energy’s Oak Ridge National Laboratory (ORNL) is engaged in a broad portfolio of scientific research for improved mobility
A new method developed at Oak Ridge National Laboratory improves the energy efficiency of a desalination process known as solar-thermal evaporation.
Scientists at Oak Ridge National Laboratory studying quantum communications have discovered a more practical way to share secret messages among three parties, which could ultimately lead to better cybersecurity for the electric grid
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.